. 2019 Jan 29;14(1):e0211268. doi: 10.1371/journal.pone.0211268

Table 2. Confirmed HCs.

cells	cisplatin	carboplatin	oxaliplatin
PANC-1	Beta-Escin^c, Camptothecine (S,+)^d, Daunorubicin^a^,^c, Hycanthone^c, Pyrvinium pamoate^c, Spironolactone^c, Topotecan^d, Vorinostat^c	Aminacrine^c, Camptothecine (S,+)^c, Daunorubicin^a^,^c, Hycanthone^c, Pyrvinium pamoate^c, Topotecan^c	Pyrvinium pamoate^c, Suloctidil^c, Topotecan^c,
A549	Auranofin^c, Azacytidine-5^c, Camptothecine (S,+)^a^,^d, Cladribine^c, Cytarabine^c, Gemcitabine^c, Pyrvinium pamoate^d, Topotecan^d, Vorinostat^d,	Aminacrine^d, Auranofin^c, Azacytidine-5^b, Cytarabine^c, Daunorubicin^a^,^b, Deferoxamine^b Floxuridine^b, Flumethasone^b, Gemcitabine^d, Pyrvinium pamoate^c	Auranofin^d, Camptothecine (S,+)^a^,^d, Erlotinib^b, Fluvastatin^b, Gemcitabine^b, Haloprogin^c, Terfenadine^d, Topotecan^d, corticosteroids^b^,^e

^a identified only in the c(PCL) = 0.83 μM experimental setting

^b HCs with the Pt drug at c ≈ IC₂₀ μM

^c HCs with the Pt drug at c ≈ IC₅₀ μM

^d HCs with the Pt drug at both concentrations

^e corticosteroid drugs: triamcinolone, prednicarbate, hydrocortisone base, prednisolone, flumethasone, fluocinolone acetonide, deflazacort, flunisolide, fludrocortisone acetate, dexamethasone acetate and desonide.